
无数据
无数据
无数据
| CAS Number | 102767-28-2 |
| Catalog Number | AG0008BR(AGN-PC-0ORTKZ) |
| Chemical Name | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide |
| EC Number | 600-348-9 |
| IUPAC Name | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide |
| InChI | InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1 |
| InChI Key | HPHUVLMMVZITSG-LURJTMIESA-N |
| MDL Number | MFCD03265610 |
| Molecular Formula | C8H14N2O2 |
| Molecular Weight | 170.2090 |
| NSC Number | 760119 |
| SMILES | O=C1N(CCC1)[C@H](C(=O)N)CC |
| UNII | 44YRR34555 |
| Synonyms | alpha ethyl 2 oxo 1 Pyrrolidineacetamide,
alpha-ethyl-2-oxo-1-pyrrolidineacetamide,
etiracetam,
Etiracetam, (R)-,
Etiracetam, R isomer,
etiracetam, R-isomer,
Etiracetam, S isomer,
etiracetam, S-isomer,
Keppra,
levetiracetam,
R-isomer Etiracetam,
S-isomer Etiracetam,
UCB 6474,
ucb L059,
ucb L060,
UCB-6474,
ucb-L059,
ucb-L060,
UCB6474,
UcbL060,
Levetiracetam,
102767-28-2,
Keppra,
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide,
Keppra XR,
ucb L059,
Levetiracetamum,
UCB-L 059,
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide,
UCB-L059,
Spritam,
(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide,
SIB-S1,
(-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide,
UNII-44YRR34555,
1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-,
MFCD03265610,
UCB-22059,
Levetiracetamum [INN-Latin],
Levetiractam,
CHEBI:6437,
ucb L060,
Levetiracetam In Sodium Chloride,
44YRR34555,
Levroxa,
(S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide,
1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (S)-,
(S)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE,
etiracetam, S-isomer,
matever,
Leviteracetam,
Levipil,
Torleva,
Elepsia XR,
(S)-Levetiracetam,
SMR000466303,
Keppra (TN),
Levesam 500,
Etiracetam levo-isomer,
SR-01000759400,
Levetiracetame,
E Keppra,
HSDB 7528,
Keppra;Keppra XR,
Levetiracetam [USAN:USP:INN:BAN],
E keppra (TN),
(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide,
AC1NR4PY,
L-059,
2(S)-(2-OXOPYRROLIDIN-1-YL)BUTYRAMIDE,
CHEMBL1286,
MLS000759403,
MLS001424069,
MLS006010215,
BIDD:GT0242,
SCHEMBL118843,
GTPL6826,
DTXSID9023207,
Levetiracetam (JAN/USAN/INN),
CTK3J2270,
KS-00000ILW,
HPHUVLMMVZITSG-LURJTMIESA-N,
Levetiracetam, >=98% (HPLC),
Levetiracetam, analytical standard,
HMS2051D07,
HMS2089L20,
HMS2235I18,
HMS3262H11,
HMS3713P16,
Pharmakon1600-01502265,
ACT02712,
ALBB-027275,
BCP11856,
HY-B0106,
ZINC1547851,
Tox21_500835,
ANW-41693,
BDBM50422542,
NSC760119,
s1356,
STL388027,
UCB 22059,
Levetiracetam 1.0 mg/ml in Methanol,
AKOS015841981,
AB13957,
AC-1479,
CCG-100928,
CS-1854,
DB01202,
KS-1176,
LP00835,
LS41261,
MCULE-5120797917,
NC00178,
NSC-760119,
RP23251,
RTC-063977,
(2S)-(2-Oxopyrrolidin-1-yl)butyramide,
NCGC00186028-01,
NCGC00261520-01,
(S)-2-(2-oxopyrrolidin-1-yl)butyramide,
AJ-26885,
BC208262,
BR-72955,
CJ-24357,
CPD000466303,
SAM001246539,
SC-15831,
(s)-2-(2-oxopyrrolidin-1-yl) butyramide,
(2S)-2-(2-oxo-1-pyrrolidinyl)butanamide,
AB0012613,
AB2000064,
LS-137054,
ST2408279,
TL8000131,
AM20070676,
FT-0082600,
FT-0602577,
L0234,
SW197558-3,
C07841,
D00709,
M-2814,
AB00639945-06,
AB00639945_07,
AB00639945_08,
767L282,
A800616,
(?S)?-?-?Ethyl-?2-?oxo-1-?pyrrolidineacetamide,
(2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide,
Q-201292,
SR-01000759400-4,
SR-01000759400-5,
(ALPHAS)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE,
UNII-230447L0GL component HPHUVLMMVZITSG-LURJTMIESA-N,
Levetiracetam, European Pharmacopoeia (EP) Reference Standard,
Levetiracetam, United States Pharmacopeia (USP) Reference Standard,
Levetiracetam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
Levitiracetam, Pharmaceutical Secondary Standard; Certified Reference Material,
Etiracetam,
Levetriacetam,
Levetiracetam [INN],
R-isomer Etiracetam,
S-isomer Etiracetam,
(-)-Levetiracetam,
Etiracetam, (R)-,
etiracetam, R-isomer,
Etiracetam, R isomer,
Etiracetam, S isomer,
ucb-L060,
UcbL060,
D01XRM,
D0E1XL,
C8H14N2O2,
UCB 6474,
UCB-6474,
Levetiracetam, 98% - 1g 1g,
UCB6474,
Keppra, Keppra XR),Levetiracetam,
C8-H14-N2-O2,
CID5284583,
alpha ethyl 2 oxo 1 Pyrrolidineacetamide,
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide,
A1198,
(alpha S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide,
D000077287,
Levetiracetam; (S)-2-(2-oxopyrrolidin-1-yl)butanamide,
114915-28-5,
|
| Complexity | 203 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 170.106g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 12 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 170.212g/mol |
| Monoisotopic Mass | 170.106g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 63.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H319 |
| Packing Group | |
| Precautionary statements | P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

